Dubovsky Filip 4
4 · NOVAVAX INC · Filed Mar 11, 2024
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Dubovsky Filip
President, R&D
Transactions
- Exercise/Conversion
Common Stock
2024-03-07+19,444→ 73,226 total - Tax Payment
Common Stock
2024-03-07$5.61/sh−9,392$52,689→ 63,834 total - Exercise/Conversion
Restricted Stock Units
2024-03-07−19,444→ 0 total→ Common Stock (38,886 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F2]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date